These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 38545106)

  • 21. Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.
    Janovec V; Hodek J; Clarova K; Hofman T; Dostalik P; Fronek J; Chlupac J; Chaperot L; Durand S; Baumert TF; Pichova I; Lubyova B; Hirsch I; Weber J
    Sci Rep; 2020 Jul; 10(1):12767. PubMed ID: 32728070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.
    Luangsay S; Ait-Goughoulte M; Michelet M; Floriot O; Bonnin M; Gruffaz M; Rivoire M; Fletcher S; Javanbakht H; Lucifora J; Zoulim F; Durantel D
    J Hepatol; 2015 Nov; 63(5):1077-85. PubMed ID: 26144659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese.
    He D; Tao S; Guo S; Li M; Wu J; Huang H; Guo X; Yan G; Zhu P; Wang Y
    Liver Int; 2015 Aug; 35(8):1941-9. PubMed ID: 25469587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The IL-1R/TLR signaling pathway is essential for efficient CD8
    Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M
    Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri.
    Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K
    Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
    Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
    J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
    Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
    Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections.
    Du K; Liu J; Broering R; Zhang X; Yang D; Dittmer U; Lu M
    Expert Opin Drug Discov; 2018 Jul; 13(7):661-670. PubMed ID: 29772941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication].
    Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
    Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
    J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.
    Lien E; Zipris D
    Curr Mol Med; 2009 Feb; 9(1):52-68. PubMed ID: 19199942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Toll-like receptors in liver health and disease.
    Broering R; Lu M; Schlaak JF
    Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility.
    Gao Y; Guo J; Zhang F; Guo Z; Zhang LR; Wang T; Wang B; Feng SY; Wang SP
    Epidemiol Infect; 2015 Jul; 143(9):1868-75. PubMed ID: 25388852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
    Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
    BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of regulatory B cells in patients with chronic hepatitis B virus infection in different immune phases.
    Wang G; Liu Y; Huang R; Jia B; Su R; Sun Z; Tian C; Xiong Y; Xia J; Yan X; Zhang Z; Wu C
    Discov Med; 2017 May; 23(128):295-304. PubMed ID: 28715645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients.
    Elbrolosy AM; Elabd NS; ElGedawy GA; Abozeid M; Abdelkreem M; Montaser B; Eed EM; Elhamouly MS
    Clin Exp Med; 2023 Feb; 23(1):117-129. PubMed ID: 35119591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Toll-like receptors in viral hepatitis].
    Kozłowska J; Jabłońska J; Wiercińska-Drapało A
    Postepy Hig Med Dosw (Online); 2009 Jul; 63():351-4. PubMed ID: 19644151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
    Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
    Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.